News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Vicor reported Q1 beat and surging backlog, citing hyperscaler AI demand and supporting a tactical mid-term long.
  • Alibaba is about 45% below its 52-week high, prompting a tactical mid-position buy plan for mid-term traders.
  • Goldman lowers 2026–27 smartphone shipment forecasts, citing high memory prices from AI demand that raise average selling prices.
  • KOSPI rally coincides with sharp won weakness, with BofA blaming foreign outflows and heavy currency-hedging demand.
  • Israeli strikes and gunfire killed at least five Palestinians, including a child, in Gaza, health officials say.
  • A judge ordered Spain's prime minister's wife to stand trial on alleged contract abuse, imposing travel and reporting restrictions.

Latest Articles

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Clearmind Medicine Inc., a clinical-stage biotech company specializing in non-hallucinogenic neuroplastogen-derived therapeutics, will host a live webinar on June 10, 2026 to discuss new clinical data from its ongoing FDA-approved Phase I/IIa trial of CMND-100, a MEAI-based oral drug candidate for Alcohol Use Disorder treatment. The webinar feature…

TD Cowen Lifts 2030 Global GLP-1 Sales Forecast to $150 Billion

TD Cowen Lifts 2030 Global GLP-1 Sales Forecast to $150 Billion

TD Cowen has upgraded its estimate for global sales of GLP-1 therapies to $150 billion by 2030, up from $139 billion, and now anticipates about 59 million patients receiving treatment by that year. The firm expects oral weight-loss formulations to secure a larger slice of the market and projects continued dominance by Eli Lilly and Novo Nordisk.

Buying Broadcom After the Drop: Tactical Long on a Calmer AI Story

Buying Broadcom After the Drop: Tactical Long on a Calmer AI Story

Broadcom shares plunged after guidance disappointed overheated expectations, but the underlying business still shows rapid AI revenue growth, strong free cash flow, and heavyweight customers. This trade targets a mid-term rebound back toward the stock's recent highs while keeping a tight stop to limit downside if guidance proves conservative.

SpaceX Bars Investors in China and Hong Kong From $75 Billion IPO

SpaceX Bars Investors in China and Hong Kong From $75 Billion IPO

SpaceX has directed underwriters for its planned $75 billion initial public offering to refuse investment orders originating from Hong Kong and mainland China, according to people briefed on the matter. The company also restricted access to its website from internet addresses in Hong Kong and Shanghai, and banks working on the deal pointed to U.S. …

Kepler Upgrades Vestas to Buy as Order Volumes Reach Six-Year High

Kepler Upgrades Vestas to Buy as Order Volumes Reach Six-Year High

Kepler Cheuvreux has raised its recommendation on Vestas Wind Systems A/S from Hold to Buy, pointing to a more attractive risk-reward profile following recent share price weakness and the company's strongest order intake volumes in nearly six years. The broker's analysis highlights supportive European policy moves, stable turbine pricing, normalize…

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Seres Therapeutics announced two financial transactions: a $25 million milestone buy-out agreement with Nestlé Health Science for their former VOWST business, and a restructured lease agreement reducing ongoing costs. These moves improve Seres' balance sheet, lower facility expenses, and extend their operating cash runway well into the first quarte…

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

Portillo's, a Chicago-born fast-casual restaurant chain known for Italian beef sandwiches and Chicago-style hot dogs, is opening a new flagship restaurant on Michigan Avenue, marking its first inline location in Chicago and continuing its expansion. This location emphasizes the brand's connection to its roots and reflects a broader growth strategy …

Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development

Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development

Climb Bio announced promising initial Phase 1 safety and pharmacometric modeling data for CLYM116, its anti-APRIL monoclonal antibody targeting IgA nephropathy (IgAN). The favorable safety profile in healthy volunteers supports continued clinical development. The company plans further data presentations and expects dosing initiation in IgAN patient…

Merz Urges EU to Demonstrate Readiness to Absorb Western Balkans at Tivat Summit

Merz Urges EU to Demonstrate Readiness to Absorb Western Balkans at Tivat Summit

Speaking at a summit in Tivat, Montenegro on June 5, German Chancellor Friedrich Merz said the European Union must be both willing and able to accept new members. The gathering brought together EU leaders and officials from six Western Balkan countries seeking accession, with enlargement back on the agenda amid concerns over foreign influence in th…